Abstract
Background
Primary hyperparathyroidism (PHPT) has a variable clinical presentation. Symptomatic PHPT continues to be the predominant form of the disease in the Indian subcontinent, but a decreasing trend of symptomatic cases is observed, and increasing numbers of asymptomatic cases are now being diagnosed. In these cases, 25-hydroxy vitamin D [25(OH)D] shows no correlation with the serum levels of calcium and intact parathyroid hormone (iPTH).
Objective
To study the characteristics of patients with hyperparathyroidism and the relationship of 25(OH)D with the levels of calcium and i PTH.
Methods
A study was conducted with 78 consecutive patients diagnosed from 1996 to 2018 with PHPT, in whom the vitamin D status was investigated preoperatively.
Results
Of the 78 study subjects, 67 (85.7%) were females and 11 (14.2%) were males. Their age ranged from 16 to 70 years. Nephrolithiasis was the single most common presentation (44.3%) followed by bone pain (42.6%). Only 5% of the subjects were asymptomatic, with a decreasing trend of symptomatic cases and increasing number of asymptomatic cases with time. Their mean serum calcium level was 11.5±1.0 mg/dl, mean serum iPTH level 377±386.1 pg/ml, mean 25(OH)D level 37.2±58.1 ng/ml, while 48% of the patients were vitamin D deficient.
The serum levels of 25(OH)D showed no correlation with serum calcium and iPTH levels, whereas it showed a negative correlation with tumor size. Neck ultrasound (US) was indicative of parathyroid pathology and laterality in 89.8% and showed the exact site of the parathyroid pathology in 63.3%. Technetium99sestamibi (MIBI) scan was indicative of parathyroid pathology (side accuracy) in 92.5% and showed the exact site in 85.7% of patients.
A single parathyroid gland was involved in 90% of study subjects, double glands in 8% and multiple glands/hyper-plasia in 1.6%. Histopathological examination showed parathyroid adenoma in 86.3% and parathyroid hyperplasia in 7.8%. Temporary post-operative hypocalcemia was detected in 36% of the patients; the cure rate was 98.4%, without any operative mortality.
Conclusion
Primary hyperparathyroidism continues to be mainly a symptomatic disease in the Kashmir Valley. There is a decreasing trend of symptomatic cases and an increasing number of asymptomatic cases with time. The level of 25(OH)D has no correlation with serum calcium, iPTH or tumor size in these patients.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Silverberg SJ, Bilezikian JP. Primary. hyperparathyroidism: still evolving? J Bone Miner Res 1997;12:856–62.
Lundgren E, Rastad J, Thrufjell E, et al. Population-based screening for primary hyperparathyroidismwith serum calcium and parathyroid hormone values in menopausal women. Surgery 1997;121:287–94.
Mithal A, Agarwal G, Singh AK, et al. Severe bone disease in primary hyperparathyroidism in Indians: A re-ection of calcium and vitamin D nutritional status? J Bone Miner Res 1997;12(Suppl):522.
Harinarayan CV, Gupta N, Kochupillai N. Vitamin D status in primary hyperparathyroidism in India. Clin Endocrinol 1995;43:351–8.
Ingemansson SG, Hugosson CH, Woodhouse NJY. Vitamin D deficiency and hyperparathyroidism with severe bonedisease. World J Surg 1988;12:517–21.
Meng XW, Xing X P, Liu SQ, et al. The diagnosis of primary hyperparathyroidism - analysis of 134 cases. Acta Academiae Medicinae Sinicae 1994;16:13.
Cheung PS, Boey YH, Wang CC, et al. Primary hyperparathyroidism: Its clinical pattern and results of surgical treatment in Hong Kong Chinese. Surgery 1988;103:558–62.
Kulak CAM, Bandeira C, Voss D, et al. Marked improvement in bone mass after parathyroidectomy in osteitis ®brosa cystica. J Clin Endocrinol Metab 1998;83:732–5.
Rao DS. Role of vitamin D and calcium nutrition in parathyroid growth and disease expression. In: Mithal A, Rao DS, Zaidi M, editors. Metabolic Bone Disorders. Lucknow: Indian Society of Bone Mineral Research; c1998. p. 25–8.
Silverberg SJ, Shane E, Dempster DW, et al. The effects of vitamin D insuf®ciency in patients with primary hyperparathyroidism. Am J Med 1999;107:561–7.
Bilezikian JP, Khan AA, Potts JT Jr, Third International Workshop on the Management of Asymptomatic Primary Hyperthyroidism. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocri nol Metab 2009;94:335–9.
Marcocci C, Cetani F. Clinical practice. Primary hyperparathyroidism. N Engl J Med 2011;365:2389–97.
Ohe MN, Santos RO, Barros ER, et al. Changes in clinical and laboratory findings at the time of diagnosis of primary hyperparathyroidism in a University Hospital in São Paulo from 1985 to 2002. Braz J Med Biol Res 2005;38:1383–7.
Wermers RA, Khosla S, Atkinson EJ, et al. Incidence of Primary Hyperparathyroidism in Rochester, Minnesota, 1993–2001: An Update on the Changing epidemiology of the Disease. J Bone Miner Res 2006;21:171–7.
Mishra SK, Agarwal G, Kar DK, et al. Unique clinical characteristics of primary hyperparathyroidism in India. British Journal of Surgery 2001;88:708–14.
Hauache OM, Amarante ECJ, Mendoza B, et al. ItAnáliseclínica, laboratorial e achadoscirúrgicos de 28 casos de hiperparati-roidismoprimário. ArquivosBrasileiros de Endocrinologia e Metabologia 1995;39:157–62.
Bilezikian JP, Meng X, Shi Y, et al. Primary hyperparathyroidism in women: A tale of two cities: New York and Beijing. International Journal of Fertility and Women’s Medicine 2000;45:158–65.
Silverberg SJ. Natural history of primary hyperparathyroidism. Endocrinol Metab Clin North Am 2000;29:451–64.
Eigelberger MS, Clark OH. Surgical approaches to primary hyperparathyroidism. Endocrinol Metab Clin North Am 2000;29:479–502.
Parmar Girish, M. Lala, M. Chadha, N. F. Shah, P. H. Chauhan. Study of Primary Hyperparathyroidism. Indian J Endocrinol Metab 2012;16(Suppl 2):S418–20.
Mithal A, Kaur P, Singh VP, et al. Asymptomatic primary hyperparathyroidism exists in North India: Retrospective data from 2 tertiary care centers. Endocr Pract 2015;21:581–5.
Parfitt AM, Rao DS, Kleerekoper M. Asymptomatic primary hyperparathyroidism discovered by multichannel biochemical screening: Clinical course and considerations bearing on the need for surgical intervention. J Bone Miner Res 1991;6 Suppl 2:S97–101.
Bhansali A, Masoodi SR, Reddy KS, et al. Primary. hyperparathyroidism in North India: A description of 52 cases. Ann Saudi Med 2005;25:29–35.
Gopal RA, Acharya SV, Bandgar T, et al. Clinical profile of primary hyperparathyroidism from Western India: A single center experience. J Postgrad Med 2010;56:79–84.
Priya G, Jyotsna VP, Gupta N, et al. Clinical and laboratory profile of primary hyperparathyroidism in India. Postgrad Med J 2008;84:34–9.
Heath H 3rd. Clinical spectrum of primary hyperparathy-roidism: Evolution with changes in medical practice and technology. J Bone Miner Res 1991;6 Suppl 2:S63–70.
Pradeep PV, Jayashree B, Mishra A, et al. Systematic review of primary hyperparathyroidism in India: The past, present, and the future trends. Int J Endocrinol [Internet] 2011:921814. Available from: https://www.hindawi.com/journals/ije/2011/921814/
Cope O. The study of hyperparathyroidism at the Massachusetts General Hospital. N Engl J Med 1966;274:1174–82.
AACE/AAES Task Force on Primary Hyperparathyroidism. The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism. Endocr Pract 2005;11:49–54.
Udelsman R. Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg 2002;235:665–70.
Soin AS, Gupta S, Kochupillai N, et al. Primary hyperparathyroidism - An Indian study. Indian J Cancer 1994;31:72–7.
Pradeep PV, Mishra A, Agarwal G, et al. Long-term outcome after parathyroidectomy in patients with advanced primary hyperparathyroidism and associated Vitamin D deficiency. World J Surg 2008;32:829–35.
Kapur MM, Agarwal MS, Gupta A, et al. Clinical & biochemical features of primary hyperparathyroidism. Indian J Med Res 1985;81:607–12.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest: The authors declare that they have no conflict of interest. They also state that they have full control of all primary data and that they agree to allow the journal to review their data if requested.
Rights and permissions
About this article
Cite this article
Dar, P.M.U.D., Malik, L.A., Wani, A.A. et al. Primary Hyperparathyroidism in a Predominantly Vitamin D Deficient Population: A Single Center Experience. Hellenic J Surg 91, 153–158 (2019). https://doi.org/10.1007/s13126-019-0526-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13126-019-0526-y